Related references
Note: Only part of the references are listed.Cancer Cells Co-opt the Neuronal Redox-Sensing Channel TRPA1 to Promote Oxidative-Stress Tolerance
Nobuaki Takahashi et al.
CANCER CELL (2018)
The ERBB network facilitates KRAS-driven lung tumorigenesis
Bjorn Kruspig et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Colorectal Tumors Require NUAK1 for Protection from Oxidative Stress
Jennifer Port et al.
CANCER DISCOVERY (2018)
EGFR in Tumor-Associated Myeloid Cells Promotes Development of Colorectal Cancer in Mice and Associates With Outcomes of Patients
Sriram Srivatsa et al.
GASTROENTEROLOGY (2017)
A Molecular Mechanism To Switch the Aryl Hydrocarbon Receptor from a Transcription Factor to an E3 Ubiquitin Ligase
Sandra Luecke-Johansson et al.
MOLECULAR AND CELLULAR BIOLOGY (2017)
Metabolic Interactions in the Tumor Microenvironment
Costas A. Lyssiotis et al.
TRENDS IN CELL BIOLOGY (2017)
SynergyFinder: a web application for analyzing drug combination dose-response matrix data
Aleksandr Ianevski et al.
BIOINFORMATICS (2017)
The paradoxical functions of EGFR during breast cancer progression
Remah Ali et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2017)
Noncoding somatic and inherited single-nucleotide variants converge to promote ESR1 expression in breast cancer
Swneke D. Bailey et al.
NATURE GENETICS (2016)
Targeting metabolism in breast cancer: How far we can go?
Jing-Pei Long et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2016)
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chih-Hao Chang et al.
CELL (2015)
Emerging Functions of Amphiregulin in Orchestrating Immunity, Inflammation, and Tissue Repair
Dietmar M. W. Zaiss et al.
IMMUNITY (2015)
Cancer immunotherapy by targeting IDO1/TDO and their downstream effectors
Michael Platten et al.
FRONTIERS IN IMMUNOLOGY (2015)
Oncogenic signaling in amphiregulin and EGFR-expressing PTEN-null human breast cancer
Christiana S. Kappler et al.
MOLECULAR ONCOLOGY (2015)
Human breast cancer cells educate macrophages toward the M2 activation status
Sofia Sousa et al.
BREAST CANCER RESEARCH (2015)
The Aryl Hydrocarbon Receptor: Multitasking in the Immune System
Brigitta Stockinger et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
TGFα and Amphiregulin Paracrine Network Promotes Resistance to EGFR Blockade in Colorectal Cancer Cells
Sebastijan Hobor et al.
CLINICAL CANCER RESEARCH (2014)
Tumor-Associated Macrophages: From Mechanisms to Therapy
Roy Noy et al.
IMMUNITY (2014)
Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer
Matt I. Gross et al.
MOLECULAR CANCER THERAPEUTICS (2014)
The Ah Receptor Regulates Growth Factor Expression in Head and Neck Squamous Cell Carcinoma Cell Lines
Kaarthik John et al.
MOLECULAR CARCINOGENESIS (2014)
EGFR has a tumour-promoting role in liver macrophages during hepatocellular carcinoma formation
Hanane Lanaya et al.
NATURE CELL BIOLOGY (2014)
The ErbB/HER family of protein-tyrosine kinases and cancer
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2014)
Estrogen controls the survival of BRCA1-deficient cells via a PI3K-NRF2-regulated pathway
Chiara Gorrini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The cellular and molecular origin of tumor-associated macrophages
Ruth A. Franklin et al.
SCIENCE (2014)
The aryl hydrocarbon receptor meets immunology: friend or foe? A little of both
Walker Julliard et al.
FRONTIERS IN IMMUNOLOGY (2014)
Aryl hydrocarbon receptor ligands in cancer: friend and foe
Iain A. Murray et al.
NATURE REVIEWS CANCER (2014)
Mitochondrial reactive oxygen species and cancer
Lucas B. Sullivan et al.
CANCER & METABOLISM (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target
Luika A. Timmerman et al.
CANCER CELL (2013)
Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
Chih-Hao Chang et al.
CELL (2013)
Minimal Differentiation of Classical Monocytes as They Survey Steady-State Tissues and Transport Antigen to Lymph Nodes
Claudia Jakubzick et al.
IMMUNITY (2013)
Amphiregulin Enhances Regulatory T Cell-Suppressive Function via the Epidermal Growth Factor Receptor
Dietmar M. W. Zaiss et al.
IMMUNITY (2013)
BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival
Chiara Gorrini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Modulation of oxidative stress as an anticancer strategy
Chiara Gorrini et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Indoleamine 2,3 dioxygenase and metabolic control of immune responses
David H. Munn et al.
TRENDS IN IMMUNOLOGY (2013)
Metabolic regulation by p53
Oliver D. K. Maddocks et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Christiane A. Opitz et al.
NATURE (2011)
Regulation of cancer cell metabolism
Rob A. Cairns et al.
NATURE REVIEWS CANCER (2011)
Amphiregulin Promotes BAX Inhibition and Resistance to Gefitinib in Non-small-cell Lung Cancers
Benoit Busser et al.
MOLECULAR THERAPY (2010)
CH223191 Is a Ligand-Selective Antagonist of the Ah (Dioxin) Receptor
Bin Zhao et al.
TOXICOLOGICAL SCIENCES (2010)
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Fernando O. Martinez et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Cross-talk between Transcription Factors AhR and Nrf2: Lessons for Cancer Chemoprevention from Dioxin
John D. Hayes et al.
TOXICOLOGICAL SCIENCES (2009)
Constitutive regulation of CYP1B1 by the aryl hydrocarbon receptor (AhR) in pre-malignant and malignant mammary tissue
Xinhai Yang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Subsets of myeloid-derived suppressor cells in tumor-bearing mice
Je-In Youn et al.
JOURNAL OF IMMUNOLOGY (2008)
The ADAM17-amphiregulin-EGFR axis in mammary development and cancer
Mark D. Sternlicht et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2008)
Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer
Xiaoling Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
TheEGF receptor family: spearheading a merger of signaling and therapeutics
Erez M. Bublil et al.
CURRENT OPINION IN CELL BIOLOGY (2007)
Tuning inflammation and immunity by chemokine sequestration: decoys and more
Alberto Mantovani et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Aryl hydrocarbon receptor-dependent liver development and hepatotoxicity are mediated by different cell types
JA Walisser et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Increases of amphiregulin and transforming growth factor-α in serum as predictors of poor response to gefitinib among patients with advanced non-small cell lung cancers
N Ishikawa et al.
CANCER RESEARCH (2005)
Tobacco smoke stimulates the transcription of amphiregulin in human oral epithelial cells: Evidence of a cyclic AMP-responsive element binding protein-dependent mechanism
BH Du et al.
CANCER RESEARCH (2005)
The chemokine system in diverse forms of macrophage activation and polarization
A Mantovani et al.
TRENDS IN IMMUNOLOGY (2004)
Share Paper
